<DOC>
	<DOC>NCT02721472</DOC>
	<brief_summary>The purpose of this study is to evaluate the relationship between plasma DNA levels and micro- and macro-circulatory vascular remodelling in patients with sickle cell disease</brief_summary>
	<brief_title>Plasma DNA and Vascular Remodelling in Patients With Sickle Cell Disease</brief_title>
	<detailed_description />
	<mesh_term>Anemia, Sickle Cell</mesh_term>
	<mesh_term>Vascular Remodeling</mesh_term>
	<criteria>Age ≥ 18 years. Homozygous SS or Sß0 sickle cell disease patients. Seen in consultation for an annual clinical and paraclinical evaluation of his/her disease. Stable clinical condition of the disease defined as the absence of severe vasoocclusive crises (requiring hospitalisation or a visit to the emergency unit) in the previous month and absence of transfusion in the previous 3 months. Other haemoglobinopathy Known diabetes. Recent administration of an anticoagulant treatment at curative doses (&lt; 48h before inclusion), or plateletinhibiting drugs (less than 1 week prior to inclusion). Recent transfusion (less than 3 months prior to inclusion). Pregnancy or postpartum (first 40 days after giving birth). Recent consumption of alcohol (less than 10h), coffee (less than 3h), and tobacco (less than 36h) before inclusion. Known infection with hepatitis B, C, and HIV infection. Known cancer or progressive blood disease. Known haemostasis or coagulation disorders. Progressive inflammatory or infectious diseases. Recent history (dating less than 3 months) of venous (pulmonary embolism, deep venous thrombosis) or arterial (acute coronary syndrome, stroke, peripheral arterial ischaemia) thromboembolic event. Adult patients subject to legal protection measures. Patients already involved in a therapeutic protocol. Patients not affiliated to a social security system. Noninclusion criteria related to the technical requirements of the EndoPAT: Known cardiac arrhythmia. Severe Raynaud's syndrome. Hand or arm deformity that prevents an EndoPAT analysis.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>